News | Computed Tomography (CT) | March 21, 2017

Toshiba Demonstrates Model-Based Iterative Reconstruction for Cardiac CT at ACC 2017

FIRST helps improve image quality and reduce dose

Toshiba, Aquilion One CT, model-based iterative reconstruction, MBIR, ACC 2017, FIRST, RSNA 2017

March 21, 2017 — Toshiba Medical demonstrated its Forward projected model-based Iterative Reconstruction SoluTion (FIRST) for cardiac exams at this year’s American College of Cardiology (ACC) 2017 annual meeting, March 17-19 in Washington, D.C. Available on its most advanced computed tomography (CT) systems, the Aquilion One / Genesis Edition and the Aquilion One Vision Edition, FIRST (MBIR) helps make CT exams safer, reduces noise and offers clinicians high-resolution images to make confident cardiac diagnoses.

The FIRST technology helps improve high-contrast spatial resolution while reducing radiation dose up to 85.3 percent as compared to filtered back projection* and drastically cuts the time needed for model-based CT image reconstruction. FIRST can improve high-contrast spatial resolution by up to 69 percent (1.69 times) as compared to filtered back projection* for cardiac imaging while reducing radiation dose. Utilizing the Aquilion One/Genesis Edition CT system, clinicians can offer fast chest pain triage by combining one-beat low-dose high-resolution cardiac CT angiography (CTA) with FIRST MBIR.

To learn more about trends in CT, read the article and watch the VIDEOS in "Technology Report: Computed Tomography (CT)"

For more information: www.medical.toshiba.com

* On the Aquilion One Vision (TSX-301C)

Related Content

A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a
More Deaths, Strokes Seen with Perioperative Beta Blocker One Year After Surgery

Image from presentation, "1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery," Devereaux 

News | ACC | March 20, 2018
March 20, 2018 — During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease
Trial for Gout Drug Meets Primary Endpoint, Raises Safety Concerns, image shows a CT scan showing gout in the knees.
News | ACC | March 20, 2018
March 20, 2018 — Febuxostat, a gout dr...
Canakinumab Doesn’t Prevent Prediabetes from Progressing to Diabetes according to a late-breaking study at ACC 2018.
News | ACC | March 20, 2018
March 20, 2018 — The anti-inflammatory...
Dabigatran Reduces Major Cardiovascular Complications in Patients With Myocardial Injury after Noncardiac Surgery
News | ACC | March 20, 2018
March 20, 2018 — Treatment with the blood-thinning drug dabigatran significantly reduced the risk of death, heart att
Statins May Bring Benefits at Time of Treatment for Heart Attack, Angina

Image from presentation, "Statins Evaluation in Coronary Procedures and Revascularization," Berwanger 

News | ACC | March 20, 2018
March 20, 2018 — Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broa
Overlay Init